COV

CLEO DIAGNOSTICS

• ASX·09/29 22:52

  Cleo Files Patents for its Ovarian Cancer Screening Test

• ASX·09/23 23:09

  CLEO Commences Ovarian Cancer Screening Test Development

• ASX·09/17 00:18

  Letter to Shareholders

• ASX·09/17 00:14

  Notice of Annual General Meeting/Proxy Form

• ASX·09/10 07:01

  Notice Required Under ASX Listing Rule 3.13.1-COV.AX

• ASX·09/09 23:15

  CLIA Certified Lab selected - Pivotal US Clinical Validation-COV.AX

• ASX·09/02 22:55

  CLEO Receives First Batch of Commercial Test Kits-COV.AX

• ASX·08/24 06:33

  Change of Director's Interest Notice x 4-COV.AX

• ASX·08/24 06:16

  Cleansing Notice-COV.AX

• ASX·08/24 06:14

  Application for quotation of securities - COV-COV.AX

• ASX·08/24 06:12

  Notification of cessation of securities - COV-COV.AX

• ASX·08/21 06:22

  Change in Director's Interest Notice-COV.AX

• ASX·08/20 06:01

  Appendix 4G and Corporate Governance Statement-COV.AX

• ASX·08/20 05:52

  Appendix 4E and 2026 Annual Report-COV.AX

• ASX·07/12 23:10

  CLEO Enters Analytical Validation Phase-COV.AX